HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Traditional Chinese Medicine

903.549

+14.0471.58%

Number of Gainers:9

Number of Losers:2

Number of Flat:- -

PE:- -

High:906.137

Open:889.310

Low:889.310

Close:889.503

Volume:16.86M

Turnover:67.06M

Market Cap:94.07B

Float Cap:63.83B

Loading ...

CONSUN PHARMA (01681) Included in Hang Seng Composite Index, Poised for Southbound Trading Eligibility

Modern Chinese Medicine Group Delays Circular Despatch After Exchange Waiver

Baiyunshan Pharmaceutical's Subsidiaries Apply Drugs for Renewal in China's Centralized Procurement

MT Newswires Live

Baiyunshan Pharmaceutical Gets China Nod for Changes to Mouthwash Spray's Registration

MT Newswires Live

Baiyunshan's Penicillin Sodium Injection Achieves Generic Drug Equivalence

AK Medical Holdings Wins Multiple Hospital Equipment Tenders in China

Modern Chinese Medicine Group Delays Circular Despatch to April 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1606/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1606\",,,,,undefined,":{"symbol":"BK1606","market":"HK","secType":"PLATE","nameCN":"Traditional Chinese Medicine","latestPrice":903.54913,"timestamp":1771834081246,"preClose":889.5026,"halted":0,"volume":16855000,"delay":0,"changeRate":0.015791,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":14.046509,"latestTime":"02-23 16:00:00","open":889.31,"high":906.13727,"low":889.31,"amount":67059894,"amplitude":0.018918,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771896600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1771810200000,1771819200000],[1771822800000,1771833600000]],"pbRate":0.938084,"peRate":15.364616,"turnoverRate":0.001057,"increases":9,"decrements":2,"flats":0,"marketCap":94067123584,"floatMarketCap":63830463360},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1606\",,,,,undefined,":{"symbol":"BK1606","high":906.13727,"amplitude":0.018918,"preClose":889.5026,"low":889.31,"pbRate":"0.938084","latestPrice":903.54913,"volume":16855000,"delay":0,"open":889.31,"prevYearClose":830.6915,"prevWeekClose":889.503,"prevMonthClose":878.602,"prevQuarterClose":830.692,"fiveDayClose":894.309,"twentyDayClose":888.815,"sixtyDayClose":853.621,"secType":"PLATE","market":"HK","turnoverRate":0.001057,"peRate":15.364616,"marketCap":94067123584,"floatMarketCap":63830463360,"timestamp":1771834081246,"nameCN":"Traditional Chinese Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1606\",,,,undefined,":{"bkCode":"BK1606","up":9,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1606\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1143010672","title":"CONSUN PHARMA (01681) Included in Hang Seng Composite Index, Poised for Southbound Trading Eligibility","url":"https://stock-news.laohu8.com/highlight/detail?id=1143010672","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143010672?lang=en_us&edition=fundamental","pubTime":"2026-02-13 19:08","pubTimestamp":1770980907,"startTime":"0","endTime":"0","summary":"CONSUN PHARMA (01681) has been added to the Hang Seng Composite Index, according to the quarterly review results of the Hang Seng Index Series announced by Hang Seng Indexes Company on February 13,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK4588","HSCI","VT","BK4585","VXUS","BK1606","01681"],"gpt_icon":0},{"id":"2610494379","title":"Modern Chinese Medicine Group Delays Circular Despatch After Exchange Waiver","url":"https://stock-news.laohu8.com/highlight/detail?id=2610494379","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610494379?lang=en_us&edition=fundamental","pubTime":"2026-02-12 17:48","pubTimestamp":1770889701,"startTime":"0","endTime":"0","summary":"Modern Chinese Medicine Group Co. Ltd. has announced a delay in despatching its circular related to a major transaction, originally expected by 9 February 2026. The delay is due to additional time needed to finalize information, including the consolidated audited report of the Target Group for the three years ended 31 December 2025. The Stock Exchange has granted a waiver, extending the expected despatch date to on or before 30 April 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modern Chinese Medicine Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 12, 2026, and is solely responsible for the information","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nNDL5Nv9Bj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01643","BK1606","BK1191"],"gpt_icon":0},{"id":"2610801990","title":"Baiyunshan Pharmaceutical's Subsidiaries Apply Drugs for Renewal in China's Centralized Procurement","url":"https://stock-news.laohu8.com/highlight/detail?id=2610801990","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610801990?lang=en_us&edition=fundamental","pubTime":"2026-02-12 12:50","pubTimestamp":1770871854,"startTime":"0","endTime":"0","summary":"Guangzhou Baiyunshan Pharmaceutical's  subsidiaries applied for the renewal of its drugs under China's centralized drug procurement, according to a Shanghai bourse filing on Thursday.More than 20 products were proposed for renewal as the previous procurement agreements are about to expire.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","BK1606","BK0097","600332","BK1197","BK0196","BK0012","BK0175","BK0028","BK0239","BK0183","BK1191","BK1521","00874","BK0188","BK0070","BK0096"],"gpt_icon":0},{"id":"2610364409","title":"Baiyunshan Pharmaceutical Gets China Nod for Changes to Mouthwash Spray's Registration","url":"https://stock-news.laohu8.com/highlight/detail?id=2610364409","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610364409?lang=en_us&edition=fundamental","pubTime":"2026-02-11 19:06","pubTimestamp":1770807998,"startTime":"0","endTime":"0","summary":"China's drug regulator approved changes to a supplementary drug application for a mouthwash spray made by Guangzhou Baiyunshan Pharmaceutical  subsidiary Baiyunshan Hejigong Pharmaceutical Factory.The company said 1 milliliter of the product is equivalent to 240 milligrams of medicinal slices containing 13 milligrams of menthol and 2.5 microliters of eucalyptus oil.The spray is used for mouth ulcers, gingivitis, and sore throat, the filing said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["00874","BK0097","BK0183","BK1197","BK1515","BK0028","BK0070","BK0196","BK0239","BK0188","BK1606","BK0175","BK0012","BK1191","BK1521","BK0096","600332"],"gpt_icon":0},{"id":"1124324288","title":"Baiyunshan's Penicillin Sodium Injection Achieves Generic Drug Equivalence","url":"https://stock-news.laohu8.com/highlight/detail?id=1124324288","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124324288?lang=en_us&edition=fundamental","pubTime":"2026-02-11 18:17","pubTimestamp":1770805051,"startTime":"0","endTime":"0","summary":"Baiyunshan (00874) announced that its subsidiary, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., recently received approval from the National Medical Products Administration for its...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0028","BK0070","BK0196","BK1606","BK1515","BK0012","00874","BK0097","BK0183","BK0188","BK1197","BK0175","BK0096","BK1191","BK1521","600332"],"gpt_icon":0},{"id":"2610653669","title":"AK Medical Holdings Wins Multiple Hospital Equipment Tenders in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2610653669","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610653669?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:16","pubTimestamp":1770642999,"startTime":"0","endTime":"0","summary":"AK Medical Holdings Ltd. has announced that its wholly-owned subsidiary, Beijing Yidian Lingdong Technology Co., Ltd., has successfully won the tender for the orthopedic hip surgery navigation system and other equipment at The First Affiliated Hospital, Zhejiang University School of Medicine. In addition, the Group has been awarded several tenders during December 2024 and January 2026. Notable awards include Shandong Provincial Hospital , Qingdao Hospital of Traditional Chinese Medicine  , and Peking University Third Hospital . For The First Affiliated Hospital, Zhejiang University School of Medicine, the contract value is RMB 3,980,000 . Revenue from these contracts is expected to be recognized in 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL3t0VSt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","BK1617","BK1606","00570","BK1583","BK1191","BK1100","BK1515","01789"],"gpt_icon":0},{"id":"2610763140","title":"Modern Chinese Medicine Group Delays Circular Despatch to April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2610763140","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610763140?lang=en_us&edition=fundamental","pubTime":"2026-02-09 19:03","pubTimestamp":1770634994,"startTime":"0","endTime":"0","summary":"Modern Chinese Medicine Group Co. Ltd. announced a delay in the despatch of its circular related to a major transaction, originally expected by 9 February 2026. The delay is due to additional time needed to finalize the consolidated audited report of the Target Group for the three years ended 31 December 2025. The company now expects to send the circular on or before 30 April 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modern Chinese Medicine Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL5yJkNs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01643","BK1191","BK1606"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}]}}